Cite
HARVARD Citation
Mark, C. et al. (2021). Safety of administration of BNT162b2 mRNA (Pfizer‐BioNTech) COVID‐19 vaccine in youths and young adults with a history of acute lymphoblastic leukemia and allergy to PEG‐asparaginase. Pediatric blood & cancer. 68 (11), p. n/a. [Online].